1. Home
  2. CDRE vs AVTX Comparison

CDRE vs AVTX Comparison

Compare CDRE & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadre Holdings Inc.

CDRE

Cadre Holdings Inc.

HOLD

Current Price

$34.16

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$18.84

Market Cap

982.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDRE
AVTX
Founded
2012
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
982.5M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
CDRE
AVTX
Price
$34.16
$18.84
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$39.67
$40.57
AVG Volume (30 Days)
398.7K
789.3K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
1.46%
N/A
EPS Growth
13.33
72.07
EPS
0.31
N/A
Revenue
$610,308,000.00
$27,813,137.00
Revenue This Year
$23.72
N/A
Revenue Next Year
$6.89
N/A
P/E Ratio
$109.35
N/A
Revenue Growth
7.53
2312.27
52 Week Low
$25.73
$8.41
52 Week High
$48.76
$24.27

Technical Indicators

Market Signals
Indicator
CDRE
AVTX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CDRE
AVTX

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments - the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: